Apeloa Pharmaceutical Co Ltd Total Liabilities
Apeloa Pharmaceutical Co Ltd total liabilities. Based on the latest financial reports, Apeloa Pharmaceutical Co Ltd (000739) has total liabilities worth CN¥5.68 Billion CNY (≈ $831.31 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Apeloa Pharmaceutical Co Ltd liquidity resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Apeloa Pharmaceutical Co Ltd (1994–2025)
Total liabilities of Apeloa Pharmaceutical Co Ltd from 1994 to 2025. This chart illustrates how Apeloa Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore how much of Apeloa Pharmaceutical Co Ltd's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Apeloa Pharmaceutical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Apeloa Pharmaceutical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Rompetrol Rafi
RO:RRC
|
Romania | RON2.33 Billion |
|
Liechtensteinische Landesbank Aktiengesellschaft
STU:LLS1
|
Germany | €26.48 Billion |
|
Fujian Anjoy Foods Co Ltd
SHG:603345
|
China | CN¥4.37 Billion |
|
Minor International Public Company Limited
BK:MINT
|
Thailand | ฿261.82 Billion |
|
Banijay Group NV
AS:BNJ
|
Netherlands | €9.98 Billion |
|
ENAGAS A.A. ADR1/2/EO150
F:EG40
|
Germany | €4.46 Billion |
|
Orla Mining Ltd
TO:OLA
|
Canada | CA$1.35 Billion |
|
Fosun International Limited
F:FNI
|
Germany | €547.93 Billion |
Liability Composition Analysis (1994–2025)
This chart breaks down Apeloa Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see balance sheet size of Apeloa Pharmaceutical Co Ltd.
Liquidity & Leverage Metrics
Apeloa Pharmaceutical Co Ltd Total Liabilities Ratios Explained
Apeloa Pharmaceutical Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.55 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.87 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.46 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Apeloa Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Apeloa Pharmaceutical Co Ltd (1994–2025)
The table below shows the annual total liabilities of Apeloa Pharmaceutical Co Ltd from 1994 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥5.97 Billion ≈ $873.88 Million |
-0.12% |
| 2024-12-31 | CN¥5.98 Billion ≈ $874.93 Million |
-8.54% |
| 2023-12-31 | CN¥6.54 Billion ≈ $956.60 Million |
+0.54% |
| 2022-12-31 | CN¥6.50 Billion ≈ $951.46 Million |
+63.18% |
| 2021-12-31 | CN¥3.98 Billion ≈ $583.08 Million |
+28.37% |
| 2020-12-31 | CN¥3.10 Billion ≈ $454.23 Million |
+12.69% |
| 2019-12-31 | CN¥2.75 Billion ≈ $403.08 Million |
+14.46% |
| 2018-12-31 | CN¥2.41 Billion ≈ $352.15 Million |
-8.88% |
| 2017-12-31 | CN¥2.64 Billion ≈ $386.48 Million |
-12.03% |
| 2016-12-31 | CN¥3.00 Billion ≈ $439.35 Million |
+0.82% |
| 2015-12-31 | CN¥2.98 Billion ≈ $435.80 Million |
+8.07% |
| 2014-12-31 | CN¥2.76 Billion ≈ $403.27 Million |
-1.73% |
| 2013-12-31 | CN¥2.80 Billion ≈ $410.38 Million |
+2.29% |
| 2012-12-31 | CN¥2.74 Billion ≈ $401.19 Million |
+14.46% |
| 2011-12-31 | CN¥2.40 Billion ≈ $350.49 Million |
+131.20% |
| 2010-12-31 | CN¥1.04 Billion ≈ $151.60 Million |
+8.49% |
| 2009-12-31 | CN¥954.91 Million ≈ $139.73 Million |
-1.86% |
| 2008-12-31 | CN¥973.00 Million ≈ $142.38 Million |
+12.61% |
| 2007-12-31 | CN¥864.02 Million ≈ $126.43 Million |
+4.26% |
| 2006-12-31 | CN¥828.68 Million ≈ $121.26 Million |
+13.06% |
| 2005-12-31 | CN¥732.94 Million ≈ $107.25 Million |
-1.41% |
| 2004-12-31 | CN¥743.40 Million ≈ $108.78 Million |
+39.15% |
| 2003-12-31 | CN¥534.24 Million ≈ $78.18 Million |
+35.05% |
| 2002-12-31 | CN¥395.59 Million ≈ $57.89 Million |
+20.73% |
| 2001-12-31 | CN¥327.67 Million ≈ $47.95 Million |
+84.31% |
| 2000-12-31 | CN¥177.79 Million ≈ $26.02 Million |
-16.30% |
| 1999-12-31 | CN¥212.40 Million ≈ $31.08 Million |
-6.50% |
| 1998-12-31 | CN¥227.17 Million ≈ $33.24 Million |
+32.65% |
| 1997-12-31 | CN¥171.26 Million ≈ $25.06 Million |
+49.90% |
| 1996-12-31 | CN¥114.25 Million ≈ $16.72 Million |
+15.99% |
| 1995-12-31 | CN¥98.50 Million ≈ $14.41 Million |
-7.22% |
| 1994-12-31 | CN¥106.16 Million ≈ $15.53 Million |
-- |
About Apeloa Pharmaceutical Co Ltd
Apeloa Pharmaceutical Co.,Ltd provides raw materials various pharmaceutical factories in the People's Republic of China and internationally. The company operates through API, CDMO, and Pharmaceutical segments. It offers API intermediates business, which includes cephalosporin, penicillin, psychotropic, cardiovascular and cerebrovascular, and veterinary API intermediates series; innovative drug R&… Read more